19 December 2019
Visiongain’s new report the Digital Pathology Market Report 2019-2029: Forecasts by Product (Scanner, Software, Communication System), Type (Human, Veterinary), Application (Teleconsultation, Disease Diagnosis, Drug Discovery), End User (Pharmaceutical & Biotechnology Companies), plus analysis of leading companies indicates that the global Digital Pathology market will attain $1,796.4 million revenue by 2029.
Global Digital Pathology market is expected to grow on account of increasing usage in drug development and companion diagnostics. The market is expected to grow at a healthy CAGR of 11.02% over the projected period. In addition, an increase in cancer incidence, an increase in the workload of pathologists, and an ever-increasing number of clinical and pre-clinical studies are other significant considerations attributable to the development of the digital pathology industry, and comparable trends are anticipated to reinforce the market concentration of Digital Pathology over the projected period.
Furthermore, the growing geriatric population prone to chronic circumstances is also anticipated to increase demand for sophisticated diagnostic methods. Chronic illnesses can be ascribed to elevated mortality rates, according to a research released in Medscape. It becomes essential to opt for sophisticated diagnostic and imaging options due to the elevated incidence of cardiovascular diseases.
In 2019, North America Digital Pathology market accounted for more than 30% of overall market share. Continuous deployment of R&D investments, supporting public projects related to the development of sophisticated systems, increasing digital imaging acceptance, and the existence of significant players are important contributing factors expected to boost market penetration of Digital Pathology over the forecast period.
The Asia Pacific is anticipated to grow with the fastest growth rate owing to growing penetration of digital imaging in developing economies like India, Japan and China, investments in the medical & healthcare technology field, and the presence of untapped opportunities will offer lucrative growth for digital pathology market in coming years.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.
21 July 2021
Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.
20 July 2021
Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.
14 July 2021
Digital innovation in clinical trials and renewed focus on home production will ensure a high growth market for supply chain optimisation.